SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump For President

TRUMP is currently experiencing high volatility as social media sentiment remains deeply polarized between investors celebrating the stock's meme-driven price action and critics highlighting concerns over project transparency. Community discourse is dominated by debates regarding the token's long-term viability, frequent comparisons to broader market volatility, and intense speculation about the influence of political developments on its price.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is trending after reporting solid quarterly earnings, but shares faced immediate downward pressure following the unexpected announcement that long-time CEO Shantanu Narayen plans to step down. Community sentiment is deeply divided, with some investors viewing the pullbacks as a generational buying opportunity due to strong recurring revenue and AI growth, while others remain skeptical about the firm's ability to maintain its market moat against low-cost, AI-driven competition.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is trending as investors speculate on potential integration with Xs upcoming payments platform, driving anticipation for a major price move. The community remains polarized, with many users debating the coin's utility and long-term potential while actively monitoring technical breakout levels.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is trending as investors digest news of the company's acquisition of the AI agent-focused social network Moltbook and reports of new in-house MTIA chips aimed at reducing reliance on external silicon. While some community members remain skeptical due to ongoing performance concerns and AI infrastructure spending, bulls are focused on the long-term potential of these efficiency gains and the stock's consolidation patterns near key technical support levels.

SentinelOne, Inc. engages in the provision of endpoint security software that detects, models, and predicts threat behavior to block attacks on any computing device. Its services include vigilance, support, and training. The company was founded by Tomer Weingarten and Almog Cohen in 2013 and is headquartered in Mountain View, CA.

SentinelOne Inc - Ordinary Shares - Class A

SentinelOne Inc

SentinelOne is trending as investors weigh mixed analyst price target adjustments against the company's recent milestone of surpassing $1 billion in annual revenue and steady growth in AI-driven security adoption. While the community is actively debating the stock's long-term valuation and potential as an acquisition target, sentiment remains polarized between concerns over profitability pressures and optimism regarding its position in the cybersecurity sector.

Ulta Beauty, Inc. engages in the retail of beauty products. The company has one reportable segment, which includes retail stores, salon services, and e-commerce. Its products include makeup, skin care, tools and brushes, fragrance, and bath and body. The company was founded on January 9, 1990 and is headquartered in Bolingbrook, IL.

Ulta Beauty Inc

Ulta Beauty is trending following a strong quarterly earnings report that featured a revenue beat and upwardly revised guidance, driving significant investor interest. Despite the positive results, the stock is experiencing volatile price action as the community debates whether the company can maintain momentum amidst broader consumer spending concerns.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

Market participants are fixated on the escalating Iran conflict and its immediate impact on oil supply, leading to high volatility and intense debate over whether current price moves are driven by genuine geopolitical risks or manipulative trading. The community remains deeply divided, with discussions oscillating between anticipation of a potential market squeeze and fears of a broader economic downturn caused by energy price surges and persistent inflation.

Rubrik, Inc. engages in the provision of cloud data management solutions. Its solutions include backup and recovery, VM backup, Microsoft 365, ransom ware recovery, database backup, cloud solutions, and Polaris sonar. Rubrik products include data protection, data threat analytics, data security posture and cyber recovery. The company was founded by Bipul Sinha, Arvind Jain, Soham Mazumdar, and Arvind Nithrakashyap in December 2013 and is headquartered in Palo Alto, CA.

Rubrik Inc. - Ordinary Shares - Class A

Rubrik Inc. - Class A

Rubrik is facing significant downward price pressure and high volatility, with investors expressing frustration over the disconnect between strong recent earnings results and the stock's poor performance. While some participants see a potential buying opportunity at current levels due to the company's growth in data security, many in the community are actively debating whether the selling is driven by broader sector headwinds, algorithm manipulation, or concerns regarding AI disruption.

Himax Technologies, Inc. is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The company's products include display drivers, timing controllers, wafer level optics, video and display technology solutions, liquid crystal over silicon silicon, complementary metal-oxide semiconductor image sensor, and power integrated circuit. Its products used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, car navigation, virtual reality (VR) devices and many other consumer electronics devices. Himax Technologies was founded by Biing Seng Wu and Jordan Wu on June 12, 2001 and is headquartered in Tainan, Taiwan.

Himax Technologies - ADR

Himax Technologies, Inc.

Himax Technologies is seeing heightened community discussion and significant trading volume as investors debate its pivotal role as a stealth supplier in the burgeoning co-packaged optics (CPO) market for AI data center infrastructure. While the stock has faced historical management criticism and cyclical display demand, sentiment is currently polarized by speculative reports of its integration into next-gen hardware architectures and the potential for a long-term revenue inflection.

Kyivstar Group Ltd. engages in the telecommunications and digital business. It provides mobile, digital and fixed-line services. The company was founded in 1994 and is headquartered in Dubai, United Arab Emirates.

Kyivstar Group Ltd.

Kyivstar Group (KYIV) is capturing significant investor attention following its Nasdaq debut and the launch of Starlink Direct to Cell services, with the community actively speculating on the stock as a proxy for potential peace negotiations in Ukraine. While some investors are bullish on the company's digital growth and potential for reconstruction-led upside, others remain cautious due to extreme geopolitical volatility, extreme short interest, and concerns over the stock's low float and erratic price swings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Quadrature Capital Ltd Boosts Stock Holdings in argenex SE $ARGX

Quadrature Capital Ltd raised its position in shares of argenex SE (NASDAQ:ARGX - Free Report) by 146.8% in the third quarter, according to its most recent Form 13F filing with the Securities and...

Van ECK Associates Corp Sells 5,527 Shares of argenex SE $ARGX

Van ECK Associates Corp lessened its stake in shares of argenex SE (NASDAQ:ARGX - Free Report) by 13.3% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional...

argenex SE $ARGX Shares Purchased by Natixis Advisors LLC

Natixis Advisors LLC raised its holdings in shares of argenex SE (NASDAQ:ARGX - Free Report) by 28.5% in the 3rd quarter, according to the company in its most recent disclosure with the Securities...

First Trust Advisors LP Acquires 6,215 Shares of argenex SE $ARGX

First Trust Advisors LP grew its holdings in shares of argenex SE (NASDAQ:ARGX - Free Report) by 10.6% in the third quarter, according to its most recent Form 13F filing with the Securities and...

Sands Capital Management LLC Takes $12.26 Million Position in argenex SE $ARGX

Sands Capital Management LLC bought a new position in shares of argenex SE (NASDAQ:ARGX - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and...

Capital World Investors Buys 8,422 Shares of argenex SE $ARGX

Capital World Investors increased its holdings in shares of argenex SE (NASDAQ:ARGX - Free Report) by 0.4% during the third quarter, according to its most recent 13F filing with the Securities and...

Capital International Sarl Invests $1.36 Million in argenex SE $ARGX

Capital International Sarl acquired a new stake in argenex SE (NASDAQ:ARGX - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission...

argenex (NASDAQ:ARGX) Upgraded by Deutsche Bank Aktiengesellschaft to Buy Rating

Deutsche Bank Aktiengesellschaft raised argenex from a "hold" rating to a "buy" rating in a report on Tuesday...

<ul class="summary-bullets"><li>The “go” decision was reached early, ahead of the company’s second quarter expected timeline.</li><li>The results from the interim analysis appear stronger than those reported by Sanofi's experimental drug riliprubart in its open-label mid-stage CIDP study, Truist said.</li><li>H.C. Wainwright increased its view of the probability of launch for claseprubart to 35% from a previous 26%.</li></ul>Shares of Dianthus Therapeutics, Inc. (DNTH) soared 19% on Monday after the company announced an early “go” decision for its experimental drug claseprubart in its Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) program, boosting Wall Street optimism.The company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://investor.dianthustx.com/news-releases/news-release-details/dianthus-therapeutics-announces-early-go-decision-following">said</a> that the decision was based on an analysis of data from a part of its late-stage trial in which a response rate of 50% or greater was observed. Twenty or more responders were confirmed out of the first 40 participants to complete part A of the trial and no related serious infections or discontinuations were observed, the company said.The “go” decision was reached early, ahead of the company’s second quarter expected timeline, and confirmed by an independent Data Safety Monitoring Board review, it added.The decision supports continued development of claseprubart into the pivotal portion of the trial in CIDP, the company said. Dianthus Therapeutics said that it will maintain the dose as is in the part A portion of the trial and engage with regulators to remove a lower dose arm in the part B portion.Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a rare, acquired autoimmune disorder where the immune system damages the myelin sheath of peripheral nerves, causing progressive or relapsing muscle weakness, numbness, and sensory loss. Other firms developing drugs for the condition include Sanofi (SNY) and Argenx SE (ARGX).<h2 class="st-heading-2">Wall Street Responds</h2>Truist raised the firm's price target on Dianthus to $110 from $63 and kept a ‘Buy’ rating on the shares. The results from the interim analysis appear stronger than those reported by Sanofi's experimental drug riliprubart in its open-label mid-stage CIDP study, the analyst told investors in a research note.H.C. Wainwright analyst Swayampakula Ramakanth, meanwhile, raised the firm's price target on Dianthus to $130 from $47 and kept a ‘Buy’ rating on the shares. The firm increased its view of the probability of launch for claseprubart to 35% from a previous 26% and also raised its price estimate to $450,000 per patient per annum compared to its prior $250,000 estimate.TD Cowen, which views Dianthus as "a viable takeout target," also kept a ‘Buy’ rating on the shares.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around DNTH stock jumped from ‘bullish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume increased from ‘high’ to ‘extremely high’ levels.<a href="https://stocktwits.com/symbol/DNTH">DNTH stock</a> has more than tripled over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/jim-cramer-terrific-ai-stock-pick-gev-gets-double-upgrade/cZdVrjXRIIw">Jim Cramer's 'Terrific' AI Stock Pick Is Already Up 26% YTD, And It Just Received A Double Upgrade Today — Here's Why</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Dianthus Therapeutics logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

DNTH Stock Soars After Early ‘Go’ Decision For Drug In Autoimmune Disorder Program, Boosting Wall Street Optimism For Potential Launch

Dianthus Therapeutics announced an early “go” decision for its experimental drug claseprubart in its Chronic Inflammatory Demyelinating Polyneuropathy program based on analysis of data from a part of its late-stage trial. 

Equity

argenex (NASDAQ:ARGX) Given "Outperform" Rating at Wedbush

Wedbush reiterated an "outperform" rating and issued a $1,000.00 price objective on shares of argenex in a research note on Monday...

argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.

ARGX
Argenx

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ARGX News

ARGXArgenx